Pharmaceutical US health care giant Johnson & Johnson, through its J&J Innovation unit, today announced 12 new alliances with life science companies and research institutions around the globe to explore early-stage innovation in a broad range of therapeutic areas and across pharmaceuticals, medical device and diagnostics and consumer health care. 19 June 2014